6618:HKEXJD Health International, Inc. Analysis

JD Health International Inc. is trading well below its short‑ and medium‑term moving averages, with price under the 20‑day, 50‑day and 200‑day SMAs, signaling a bearish technical backdrop. The 14‑day RSI sits in the mid‑30s, suggesting oversold conditions, while the MACD line has crossed above the signal line, producing a bullish histogram that hints at a possible short‑term reversal.
Fundamentally, the company delivers robust top‑line growth of roughly 28% YoY, solid cash generation, and a strong balance sheet with abundant cash and minimal net debt. The DCF‑derived fair value is dramatically higher than the current market price, implying near‑90% upside, and analysts collectively rate the stock as a strong buy. Recent Tipranks press releases have reinforced this positive sentiment, and the market’s “Extreme Greed” reading reflects heightened investor enthusiasm despite the technical bearishness.